SPDR® MSCI Europe Health Care UCITS ETF (EUR) | STWXRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.4 | 17.9 | 0.4 | 5.8 | 7.9 | |
+/-Cat | -14.1 | 8.5 | 5.0 | 8.9 | 4.1 | |
+/-B’mrk | - | -0.3 | -5.4 | 8.3 | 0.5 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 20/11/2024 | EUR 213.25 | |
Day Change | -0.05% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 449 | |
Exchange | BORSA ITALIANA S.P.A. | |
ISIN | IE00BKWQ0H23 | |
Fund Size (Mil) 20/11/2024 | EUR 653.42 | |
Share Class Size (Mil) 20/11/2024 | EUR 653.42 | |
Ongoing Charge 31/05/2024 | 0.18% |
Investment Objective: SPDR® MSCI Europe Health Care UCITS ETF (EUR) | STWX |
The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ludovic Brancourt 05/12/2014 | ||
Inception Date 05/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Health Care 35/20 Capped NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR® MSCI Europe Health Care UCITS ETF (EUR) | STWX | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 20.66 |
AstraZeneca PLC | Healthcare | 12.71 |
Roche Holding AG | Healthcare | 12.57 |
Novartis AG Registered Shares | Healthcare | 12.35 |
Sanofi SA | Healthcare | 6.94 |
Increase Decrease New since last portfolio | ||
SPDR® MSCI Europe Health Care UCITS ETF (EUR) | STWX |